Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. |
A: | B: |
PBMCs before separation | Enriched NK cells after depletion of non-NK cells |
Figure 1CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. | Figure 1CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. |
C: | |
Isolated CD56 + CD16 + NK cells | |
Figure 1CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. |
Our lab studies NK cell activity in the context of HIV infection and use purified NK cells from human PBMC. This kit provides reliable isolation of NK cells from this cell source.
Our laboratory investigates ways to improve immune responses against HIV, including enhancement of the capacity of NK cells to kill HIV-infected cell. For these studies we set up in vitro ADCC assays with NK cells against infected target cells. As such, we need to purify NK cells and the CD56+ CD16+ selection kit isolates this population at a high purity via a two step process, first depleting all non-NK cells, and then enriching for the CD56 and CD16 positive cells.
We used this kit in experiments where we were investigating Fc mediated functions of NK cells in the context of HIV infection. For this we needed to isolate NK cells from human PBMCs. This kit was used and consistently resulted in high purity and yield of human NK cells.
CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. |
A: | B: |
PBMCs before separation | Enriched NK cells after depletion of non-NK cells |
Figure 1CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. | Figure 1CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. |
C: | |
Isolated CD56 + CD16 + NK cells | |
Figure 1CD56 +CD16 + NK cells were isolated from human PBMCs using the CD56 +CD16 + NK Cell Isolation Kit, an LS and an MS Column, a MidiMACS™ and a MiniMACS™ Separator. Cells were fluorescently stained with CD16-FITC and CD56-PE. |
Our lab studies NK cell activity in the context of HIV infection and use purified NK cells from human PBMC. This kit provides reliable isolation of NK cells from this cell source.
Our laboratory investigates ways to improve immune responses against HIV, including enhancement of the capacity of NK cells to kill HIV-infected cell. For these studies we set up in vitro ADCC assays with NK cells against infected target cells. As such, we need to purify NK cells and the CD56+ CD16+ selection kit isolates this population at a high purity via a two step process, first depleting all non-NK cells, and then enriching for the CD56 and CD16 positive cells.
We used this kit in experiments where we were investigating Fc mediated functions of NK cells in the context of HIV infection. For this we needed to isolate NK cells from human PBMCs. This kit was used and consistently resulted in high purity and yield of human NK cells.
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.